Invitrogen Files Formal Merger Notification with EU Authorities | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen has filed a formal notification with the European Commission regarding its pending $6.7 billion acquisition of Applied Biosystems, the firm said today.
The commission has 25 business days following the notification to respond to the filing, said Invitrogen. US regulatory authorities have already cleared the merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.